On the death trk

Developmental Neurobiology

Volumn 70, Issue 5, 2010, Pages 298-303

  Harel, Liraz ^a   Costa, Barbara ^a   Fainzilber, Mike ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CCM2; Neuroblastoma; Neurotrophin; p75; Trk

Indexed keywords

CCM2 PROTEIN; GENE PRODUCT; NEUROTROPHIN 3 RECEPTOR; PROTEIN P75; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG;

CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CHILDHOOD CANCER; HUMAN; NERVOUS SYSTEM; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; TUMOR CELL;

ANIMALS; CELL DEATH; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS, NEUROEPITHELIAL; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, NERVE GROWTH FACTOR;

EID: 77949734773     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20769     Document Type: Review

References (55)

1. Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA. 2009. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): Evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18:919-930.
2. Ancot F, Foveau B, Lefebvre J, Leroy C, Tulasne D. 2009. Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity. Oncogene 28:2185-2195.
3. Bassili M, Birman E, Schor NF, Saragovi HU. Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo. Cancer Chemother Pharmacol, in press: doi 10.1007/s00280-00009-01110-x.
4. Borrello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, Pilotti S, et al. 1993. trk and ret proto-oncogene expression in human neuroblastoma specimens: High frequency of trk expression in nonadvanced stages. Int J Cancer 54:540-545.
5. Brann AB, Tcherpakov M, Williams IM, Futerman AH, Fainzilber M. 2002. Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J Biol Chem 277:9812-9818.
6. Brodeur GM. 1995. Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer A 31:505-510.
7. Brodeur GM. 2003. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
8. Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, et al. 2009. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 15:3244-3250.
9. Bronfman FC. 2007. Metalloproteases and gamma-secretase: New membrane partners regulating p75 neurotrophin receptor signaling? J Neurochem 103 (Suppl 1):91-100.
10. Chao MV. 2003. Dependence receptors: What is the mechanism? Sci STKE 2003:PE38.
11. Chen ZY, Ieraci A, Tanowitz M, Lee FS. 2005. A novel endocytic recycling signal distinguishes biological responses of Trk neurotrophin receptors. Mol Biol Cell 16:5761-5772.
12. Chou TT, Trojanowski JQ, Lee VM. 2000. A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma. J Biol Chem 275:565-570.
13. Dadakhujaev S, Jung EJ, Noh HS, Hah YS, Kim CJ, Kim DR. 2009. Interplay between autophagy and apoptosis in TrkA-induced cell death. Autophagy 5:103-105.
14. Depaepe V, Suarez-Gonzalez N, Dufour A, Passante L, Gorski JA, Jones KR, Ledent C, et al. 2005. Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature 435:1244-1250.
15. Donovan MJ, Hempstead BL, Horvath C, Chao MV, Schofield D. 1993. Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am J Pathol 143:1560-1567.
16. Eberhart CG, Kaufman WE, Tihan T, Burger PC. 2001. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules. J Neuropathol Exp Neurol 60:462-469.
17. Farina AR, Tacconelli A, Cappabianca L, Cea G, Panella S, Chioda A, Romanelli A, et al. 2009. The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability. Mol Cell Biol 29:4812-4830.
18. Gulino A, Arcella A, Giangaspero F. 2008. Pathological and molecular heterogeneity of medulloblastoma. Curr Opin Oncol 20:668-675.
19. Hansen K, Wagner B, Hamel W, Schweizer M, Haag F, Westphal M, Lamszus K. 2007. Autophagic cell death induced by TrkA receptor activation in human glioblastoma cells. J Neurochem 103:259-275.
20. Harel L, Costa B, Tcherpakov M, Zapatka M, Oberthuer A, Hansford LM, Vojvodic M, et al. 2009. CCM2 mediates death signaling by the TrkA receptor tyrosine kinase. Neuron 63:585-591.
21. Holtzman DM, Li Y, Parada LF, Kinsman S, Chen CK, Valletta JS, Zhou J, et al. 1992. p140trk mRNA marks NGF-responsive forebrain neurons: Evidence that trk gene expression is induced by NGF. Neuron 9:465-478.
22. Huang EJ, Reichardt LF. 2003. Trk receptors: Roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.
23. Iwata H, Ito T, Mutoh T, Ishiguro Y, Xiao H, Hamaguchi M. 1994. Abundant but inactive-state gp140proto-trk is expressed in neuroblastomas of patients with good prognosis. Jpn J Cancer Res 85:32-39.
24. Johnsen JI, Kogner P, Albihn A, Henriksson MA. 2009. Embryonal neural tumours and cell death. Apoptosis 14:424-438.
25. Jung EJ, Kim DR. 2008. Apoptotic cell death in TrkA-overexpressing cells: Kinetic regulation of ERK phosphorylation and caspase-7 activation. Mol Cells 26:12-17.
26. Kim JY, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, Goritchenko L, Kaufman JR, et al. 1999. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 59:711-719.
27. Kleaveland B, Zheng X, Liu JJ, Blum Y, Tung JJ, Zou Z, Chen M, et al. 2009. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 15:169-176.
28. Kogner P, Barbany G, Bjork O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, et al. 1994. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors. Prog Clin Biol Res 385:137-145.
29. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H. 1993. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044-2050.
30. Lachyankar MB, Ross AH, Litofsky NS, Condon PJ, Quesenberry PJ, Recht LD. 1997. TrkA expression decreases the in vivo aggressiveness of C6 glioma cells. Cancer Res 57:532-536.
31. Lavoie JF, Lesauteur L, Kohn J, Wong J, Furtoss O, Thiele CJ, Miller FD, et al. 2005. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. J Biol Chem 280:29199-29207.
32. Lucarelli E, Kaplan D, Thiele CJ. 1997. Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells. Eur J Cancer 33:2068-2070.
33. Matrone C, Marolda R, Ciafre S, Ciotti MT, Mercanti D, Calissano P. 2009. Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated phosphorylation. Proc Natl Acad Sci USA 106:11358-11363.
34. Merlio JP, Ernfors P, Jaber M, Persson H. 1992. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51:513-532.
35. Morley SN, Power JM, Coulson EJ, Bartlett PF. 2007. Zinc-mediated neuronal death is dependent on Trk activation. Exp Neurol 205:360-366.
36. Muragaki Y, Chou TT, Kaplan DR, Trojanowski JQ, Lee VM. 1997. Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J Neurosci 17:530-542.
37. Nakagawara A. 2004. Neural crest development and neuroblastoma: The genetic and biological link. Prog Brain Res 146:233-242.
38. Ohta T, Watanabe T, Katayama Y, Kurihara J, Yoshino A, Nishimoto H, Kishimoto H. 2006. TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas. Neuropathology 26:170-177.
39. Pagenstecher A, Stahl S, Sure U, Felbor U. 2009. A two-hit mechanism causes cerebral cavernous malformations: Complete inactivation of CCM1. CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18:911-918.
40. Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H, Hale LP, et al. 2006. Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm Genome 17:119-128.
41. Sakaue M, Mori N, Makita M, Fujishima K, Hara S, Arishima K, Yamamoto M. 2009. Acceleration of methylmercury-induced cell death of rat cerebellar neurons by brain-derived neurotrophic factor in vitro. Brain Res 1273:155-162.
42. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. 1994. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867-12871.
43. Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, et al. 2004. TrkA expression in peripheral neuroblastic tumors: Prognostic significance and biological relevance. Cancer 101:1873-1881.
44. Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. 2008. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci 28:3941-3946.
45. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. 1993. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377-384.
46. Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A, Sferra R, et al. 2004. TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6:347-360.
47. Tauszig-Delamasure S, Yu LY, Cabrera JR, Bouzas-Rodriguez J, Mermet-Bouvier C, Guix C, Bordeaux MC, et al. 2007. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci USA 104:13361-13366.
48. Tooze SA, Schiavo G. 2008. Liaisons dangereuses: Autophagy, neuronal survival and neurodegeneration. Curr Opin Neurobiol 18:504-515.
49. Ullrich NJ, Pomeroy SL. 2003. Pediatric brain tumors. Neurol Clin 21:897-913.
50. Urra S, Escudero CA, Ramos P, Lisbona F, Allende E, Covarrubias P, Parraguez JI, et al. 2007. TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal gamma-secretase-mediated release of the p75 intracellular domain. J Biol Chem 282:7606-7615.
51. Volosin M, Trotter C, Cragnolini A, Kenchappa RS, Light M, Hempstead BL, Carter BD, et al. 2008. Induction of proneurotrophins and activation of p75NTR-mediated apoptosis via neurotrophin receptor-interacting factor in hippocampal neurons after seizures. J Neurosci 28:9870-9879.
52. von Bartheld CS, Fritzsch B. 2006. Comparative analysis of neurotrophin receptors and ligands in vertebrate neurons: Tools for evolutionary stability or changes in neural circuits? Brain Behav Evol 68:157-172.
53. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, et al. 2009. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15:177-184.
54. Woo CW, Lucarelli E, Thiele CJ. 2004. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 23:1522-1530.
55. Yan C, Liang Y, Nylander KD, Schor NF. 2002. TrkA as a life and death receptor: Receptor dose as a mediator of function. Cancer Res 62:4867-4875.